These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 23429591
1. Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction. He H, Li X, Wang H, Zhang W, Jiang H, Wang S, Yuan L, Liu Y, Liu X. J Cardiovasc Pharmacol; 2013 Jun; 61(6):482-8. PubMed ID: 23429591 [Abstract] [Full Text] [Related]
2. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness. Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T. Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584 [Abstract] [Full Text] [Related]
6. Salvianolic acid A attenuated myocardial infarction-induced apoptosis and inflammation by activating Trx. Zhou R, Gao J, Xiang C, Liu Z, Zhang Y, Zhang J, Yang H. Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):991-1002. PubMed ID: 31811327 [Abstract] [Full Text] [Related]
7. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G. Endocrinology; 2008 Jun; 149(6):3148-57. PubMed ID: 18292189 [Abstract] [Full Text] [Related]
8. Melatonin prevents increased asymmetric dimethylarginine in young rats with bile duct ligation. Tain YL, Hsieh CS, Chen CC, Sheen JM, Lee CT, Huang LT. J Pineal Res; 2010 Apr; 48(3):212-221. PubMed ID: 20210851 [Abstract] [Full Text] [Related]
9. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S. J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314 [Abstract] [Full Text] [Related]
12. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways. Wang X, Wang Y, Jiang M, Zhu Y, Hu L, Fan G, Wang Y, Li X, Gao X. J Ethnopharmacol; 2011 Jun 01; 135(3):662-71. PubMed ID: 21497648 [Abstract] [Full Text] [Related]
13. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S. Nephrol Dial Transplant; 2009 Apr 01; 24(4):1162-9. PubMed ID: 19015171 [Abstract] [Full Text] [Related]
15. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue. Maas R, Tan-Andreesen J, Schwedhelm E, Schulze F, Böger RH. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May 15; 851(1-2):220-8. PubMed ID: 17296339 [Abstract] [Full Text] [Related]
16. Modulation of arginine and asymmetric dimethylarginine concentrations in liver and plasma by exogenous hydrogen sulfide in LPS-induced endotoxemia. Bekpinar S, Develi-Is S, Unlucerci Y, Kusku-Kiraz Z, Uysal M, Gurdol F. Can J Physiol Pharmacol; 2013 Dec 15; 91(12):1071-5. PubMed ID: 24289078 [Abstract] [Full Text] [Related]
17. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. Chobanyan K, Thum T, Suchy MT, Zhu B, Mitschke A, Gutzki FM, Beckmann B, Stichtenoth DO, Tsikas D. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):32-41. PubMed ID: 17825631 [Abstract] [Full Text] [Related]
18. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats. Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T. Hypertens Res; 2005 Mar 15; 28(3):255-62. PubMed ID: 16097370 [Abstract] [Full Text] [Related]
19. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II. Chobanyan-Jürgens K, Fuchs AJ, Tsikas D, Kanzelmeyer N, Das AM, Illsinger S, Vaske B, Jordan J, Lücke T. Amino Acids; 2012 Aug 15; 43(2):805-11. PubMed ID: 22075968 [Abstract] [Full Text] [Related]
20. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA. Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847 [Abstract] [Full Text] [Related] Page: [Next] [New Search]